Delivery Order SPE2DB25D3001-SPE2DB26FQTQD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,080.32. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $17,854.65, with completion scheduled for October 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,449.50 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitive, firm fixed-price delivery order will be fulfilled at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,415.98. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by October 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a competitive award, this delivery order reflects the company's demonstrated capability...
- The Defense Logistics Agency awarded a $1,379.80 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price order is due for completion by September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors for this pharmaceutical supply requirement. This delivery order...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-competitive, non-set-aside award is scheduled for completion by October 22, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction under AmerisourceBergen's larger federal contract portfolio supporting military and defense healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,449.50 on June 6, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $5,174.25. This is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,531.20 with a completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB26FQTQDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,449.00 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitively awarded, firm fixed-price delivery order will be completed by October 30, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this contract action. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medical products including vaccines, medications, and medical devices to support military healthcare systems and other federal health agencies. The company's established relationship with DLA and demonstrated capacity for managing substantial medical supply contracts position it as a key provider for federal procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 10/29/25 |